Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 4 minute read General business news Reliance Industries sees mixed fortunes in Q2 FY25! Profit down, Jio’s subscriber surge continues! Reliance Industries Limited (RIL) announced its consolidated and standalone unaudited financial results for the quarter ending September 30,… byPallavi MadhirajuOctober 15, 2024